Company Announcements - 2017
-
Notice of Option Expiry27 December 2017
Analytica gives notice of unlisted options expiring 31 January 2018.
-
Appendix 3B - Shareholder Option Exercise22 December 2017
-
Compliance Documents following Annual General Meeting4 December 2017
Analytica presents ASX compliance documents following the AGM.
-
Results of Annual General Meeting30 November 2017
Analytica presents the proxy votes for resolutions at the Annual General Meeting. The company also presents the Chairman's address to shareholders and slides from the the CEO presentation.
-
Appointment of Navigant Capital Advisors6 November 2017
Analytica is pleased to announce that New York based Investment Bank, Navigant Capital Advisors LLC has been retained by Analytica to run the process for the sale of PeriCoach, AutoStart Burette and the possible sale of the company.
-
Appendix 4C31 October 2017
Analytica presents its quarterly cash flow report for the period ending 30 Sept 2017.
-
Entitlement Offer Shortfall Share Issue31 October 2017
Analytica presents an Appendix 3B - New Issue Announcement, and a Notice under s.708A (Cleansing Statement) for shortfall securities issued following the recent Entitlement Offer.
-
Notice of Annual General Meeting and Proxy Form27 October 2016
Analytica advises that the 2017 Annual General Meeting will be held in the Oxley Room, Level 1, Christie Conference Centre, 320 Adelaide St Brisbane at 10:00am Thursday 30th November 2017. Also included with this notice are a voting proxy form with instructions.
-
Appendix 3Y x420 October 2017
Change of Director's Interest Notice for Dr Michael Monsour, Dr Peter Corr, Mr Ross Mangelsdorf, and Mr Carl Stubbings.
-
Appendix 3B19 October 2017
Analytica presents an Appendix 3B - New Issue Announcement for securities issued under the recent Entitlement Offer.
-
Completion of Entitlement Offer17 October 2017
Analytica is pleased to announce completion of its 1 for 8 Entitlement Offer.
-
Annual Report, Appendix 4G and Corporate Governance Statement28 September 2017
-
Corporate Plan Progress Update27 September 2017
Analytica is pleased to announce the next step in development of the PeriCoach® and AutoStart® Burette with the appointment of a US corporate advisory firm.
-
Replacement Prospectus26 September 2017
Analytica presents a replacement prospectus for the entitlement offer announced 18 September.
-
Entitlement Offer18 September 2017
Analytica is pleased to announce that it is proposing to undertake an equity capital raising to raise up to approximately $1.593 million (before offer costs) by way of a renounceable pro-rata entitlement offer to eligible shareholders.
-
Appendix 4E - Preliminary Final Report31 August 2017
Analytica presents its Appendix 4E and Financial Statements for the year ended 30 June 2017.
-
Response to ASX Appendix 4C Query9 August 2017
-
Appendix 4C31 July 2017
Analytica presents its quarterly cash flow report for the period ending 30 June 2017.
-
Appendix 3B28 June 2017
Analytica presents an Appendix 3B - New Issue Announcement for unlisted options issued as compensation for consultancy services.
-
Appendix 3B9 June 2017
Analytica presents an Appendix 3B - New Issue Announcement for options issued under the Employee Share Option Plan.
-
Dr Peter Corr Appointed to Board of Directors23 May 2017
Dr. Corr has been invited to join the Board due to his extensive experience in the discovery and development of medicines in multiple indications, as well as the sale of assets to major multinational corporations.
-
PeriCoach granted patent protection in Australia11 May 2017
Analytica has been granted patent protection in the Australia for the device’s unique pelvic floor force sensing technology.
-
PeriCoach Releases 8-week Challenge Exercise Programme4 May 2017
Analytica has released a scientifically-developed, structured exercise programme for the PeriCoach system App to drive motivation and exercise compliance.
-
PeriCoach Version 3 Device Released1 May 2017
Analytica has today released the first production units of the next generation Version 3 PeriCoach device.
-
Appendix 4C28 April 2017
Analytica presents its quarterly cash flow report for the period ending 31 March 2017.
-
New AUA and SUFA Surgical Guidelines for SUI.26 April 2017
Analytica draws the attention of shareholders to a recent release of evidence-based clinical guidelines for the surgical treatment of stress urinary incontinence.
-
Securities Issued after Extraordinary General Meeting24 April 2017
Analytica presents compliance documents related to the issue of securities approved at the recent EGM.
-
Results of Extraordinary General Meeting12 April 2017
Analytica presents results of the EGM held in Brisbane today. All resolutions were passed.
-
Appendix 3B and Notice under s708A17 March 2017
Analytica presents an Appendix 3B - New Issue Announcement and a statement under Section 708A.
-
Notice of Extraordinary General Meeting and Proxy Form10 March 2017
Analytica invites shareholders to attend an Extraordinary General Meeting to be held at 11.00am on Wednesday 12th April 2017 at Christie Corporate, Level 1, 320 Adelaide Street, Brisbane.
-
Appendix 3B and Notice under s708A9 March 2017
Analytica presents an Appendix 3B - New Issue Announcement and a statement under Section 708A.
-
Appendix 4D28 February 2017
Analytica presents its Appendix 4D - Half year results to 31 December 2016.
-
PeriCoach granted patent protection in Japan22 February 2017
Analytica has been granted patent protection in the Japan for the device’s unique pelvic floor force sensing technology.
-
PeriCoach Clinical Trial Reveals Marked Improvement in Quality of Life, Sexual Function and Continence.21 February 2017
-
Appendix 3B, Form 604 and Notice under s.708A16 February 2017
Analytica presents notices relating to the issue of securities. Appendix 3B - New issue announcement, application for quotation of additional securities and agreement, Form 604 - Notice of change of interests of substantial holder, and a Notice under s.708A.
-
Appendix 4C31 January 2017
Analytica presents its quarterly cash flow report for the period ending 31 Dec 2016.
-
Capital Raising Activities31 January 2017
Analytica announces a series of placements.
-
PeriCoach User Surveys Reveal Insight into Motivation and Behaviour13 January 2017
Analytica’s post-market surveillance program reveals insights into PeriCoach user demographics, behaviour and motivation factors.